- Evofem Biosciences Inc Investor Call TranscriptAug 11, 2022
- Q2 2022 Evofem Biosciences Inc Earnings Call TranscriptAug 04, 2022$112.25 (+3.22%)Earnings
- Q1 2022 Evofem Biosciences Inc Earnings Call TranscriptMay 04, 2022$308.62 (-0.24%)Earnings
- Q4 2021 Evofem Biosciences Inc Earnings Call TranscriptMar 03, 2022$918.75 (-8.12%)Earnings
- Q3 2021 Evofem Biosciences Inc Earnings Call TranscriptNov 15, 2021$1246.87 (-0.75%)Earnings
- Evofem Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Evofem Biosciences Inc Earnings Call TranscriptAug 11, 2021$1586.05 (-0.24%)Earnings
- Evofem Biosciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- Q1 2021 Evofem Biosciences Inc Earnings Call TranscriptMay 06, 2021$2287.49 (-5.43%)Earnings
- Q4 2020 Evofem Biosciences Inc Earnings Call TranscriptMar 04, 2021$6131.22 (-9.17%)Earnings
- Evofem Biosciences Inc at H C Wainwright BioConnect Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Evofem Biosciences Inc Earnings Call TranscriptNov 09, 2020$4387.48 (-4.49%)Earnings
- Evofem Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Q2 2020 Evofem Biosciences Inc Earnings Call TranscriptAug 04, 2020$5662.47 (-5.63%)Earnings
- Evofem Biosciences Inc to Discuss the FDA Approval of Phexxi - Call TranscriptMay 26, 2020
- Q1 2020 Evofem Biosciences Inc Earnings Call TranscriptMay 06, 2020$9824.95 (+2.54%)Earnings
- Q4 2019 Evofem Biosciences Inc Earnings Call TranscriptMar 12, 2020$7443.71 (-23.06%)Earnings
- Q3 2019 Evofem Biosciences Inc Earnings Call TranscriptNov 07, 2019$9543.7 (-0.20%)Earnings
- Q2 2019 Evofem Biosciences Inc Earnings Call TranscriptAug 06, 2019$9693.7 (-4.61%)Earnings
- Evofem Biosciences Inc at ROTH Conference - Fireside Chat TranscriptMar 19, 2019
- Q4 2018 Evofem Biosciences Inc Earnings Call TranscriptMar 01, 2019$6843.72 (-12.05%)Earnings
Q3 2021 Evofem Biosciences Inc Earnings Call Transcript
Thank you for standing by, and welcome to the Evofem Biosciences Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) As a reminder, today's program is being recorded.
And now I'd like to introduce your host for today's program, Amy Raskopf, Vice President of Investor Relations. Please go ahead.
Thank you. Good afternoon, everyone, and welcome to the Evofem Biosciences results call for the third quarter of 2021. If you haven't done so already, I encourage you to access the press release we issued earlier today and the presentation that accompanies this call, both of which are at evofem.com under the Investors tab.
Before we begin, I would like to remind you that remarks on this call will contain forward-looking statements, which are made only as of today, November 15, 2021. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10-Q.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)